Entera Bio Ltd.

8-K Entered a material agreement; Unregistered sale of equity; Director or officer change Jul 28, 2026 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results Jul 16, 2026 10-Q Quarter ended 2026-03-31 May 8, 2026 8-K Results of operations (earnings release); Regulation FD disclosure May 8, 2026 8-K Entered a material agreement; Unregistered sale of equity Apr 3, 2026 10-K Fiscal year ended 2025-12-31 Mar 27, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Mar 27, 2026 8-K Regulation FD disclosure Mar 4, 2026 8-K Director or officer change; Regulation FD disclosure Feb 9, 2026 8-K Entered a material agreement; Director or officer change; Regulation FD disclosure Feb 4, 2026 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 14, 2025 10-Q Quarter ended 2025-06-30 Aug 8, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 8, 2025 8-K Regulation FD disclosure; Other events Jul 28, 2025 8-K Shareholder vote results Jul 18, 2025 10-Q Quarter ended 2025-03-31 May 9, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 9, 2025 10-K Fiscal year ended 2024-12-31 Mar 28, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Mar 28, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Mar 17, 2025 8-K Jan 10, 2025 8-K/A Shareholder vote results Dec 20, 2024 10-Q Quarter ended 2024-09-30 Nov 8, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Nov 8, 2024 10-Q Quarter ended 2024-06-30 Aug 9, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 9, 2024 8-K Shareholder vote results Aug 2, 2024 10-Q Quarter ended 2024-03-31 May 10, 2024 8-K Results of operations (earnings release); Regulation FD disclosure May 10, 2024 10-K Fiscal year ended 2023-12-31 Mar 8, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Mar 8, 2024 8-K Regulation FD disclosure Mar 4, 2024 8-K Regulation FD disclosure Feb 2, 2024 8-K Other events Jan 3, 2024 8-K Entered a material agreement; Unregistered sale of equity Dec 26, 2023 10-Q Quarter ended 2023-09-30 Nov 14, 2023 8-K Results of operations (earnings release); Regulation FD disclosure Nov 14, 2023 8-K Shareholder vote results Sep 13, 2023 10-Q Quarter ended 2023-06-30 Aug 11, 2023